Erlotinib-induced complete response in a patient with epidermal growth factor receptor wild-type lung adenocarcinoma after chemotherapy failure: a case report

INTRODUCTION: The efficacy of erlotinib in advanced non-small-cell lung cancer has been demonstrated in several trials, but only two cases of complete and prolonged response in wild-type epidermal growth factor receptor locally advanced lung cancer have been published. CASE PRESENTATION: We discuss...

Descripción completa

Detalles Bibliográficos
Autores principales: Vitale, Maria Giuseppa, Riccardi, Ferdinando, Mocerino, Carmela, Barbato, Carmela, Monaco, Roberto, Galloro, Paola, Gagliardi, Nicola, Cartenì, Giacomo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978081/
https://www.ncbi.nlm.nih.gov/pubmed/24661457
http://dx.doi.org/10.1186/1752-1947-8-102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978081/
https://www.ncbi.nlm.nih.gov/pubmed/24661457
http://dx.doi.org/10.1186/1752-1947-8-102

Ejemplares similares